glp 1 agonist vs analog Strategies to Enhance the Therapeutic Efficacy of GLP‐1 Receptor Agonists through Structural Modification and Carrier Delivery - Zhang - 2025 - ChemBioChem DPP4 Inhibitors vs GLP-1 Agonists
Description
The STEP1 and SURMOUNT trials demonstrated sustained clinically relevant reduction in body weight with semaglutide and tripeptide, respectively, in patients with overweight and obesity
Beyond appetite control, it has metabolic benefits such as improving insulin sensitivity, reducing excessive insulin levels, and aiding in fat utilization
They make the drug Mounjaro, which is similar but different from Ozempic
Best for lifestyle support 9.3 Overall Score 5
Anyone with personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia type 2 should not take GLP 1 medications
